Hillrom Launches Two New Respiratory Health Innovations: Volara™ System for Oscillation and Lung Expansion Therapy, and Synclara™ Cough System
CHICAGO, July 13, 2020 - Global medical technology leader Hillrom (NYSE: HRC) today announced the launch of two new respiratory therapy devices: the Volara™ System, which provides hospital-grade oscillation and lung expansion (OLE) therapy, and the Synclara™ Cough System.
CHICAGO, June 29, 2020 - Hillrom (NYSE: HRC) will host its fiscal third quarter 2020 earnings conference call and webcast on Friday, July 31, 2020, beginning at 7:30 a.m. (CT) / 8:30 a.m. (ET).
CHICAGO, June 16, 2020 - Hillrom (NYSE: HRC) today announced the launch of the Hillrom™ Extended Care Solution, a new, connected remote vital signs monitoring device that allows clinicians to shift care closer to home.
CHICAGO, May 7, 2020 - Hillrom (NYSE: HRC) announced today that its board of directors declared a fiscal 2020 third quarter dividend of $0.22 per share payable on June 30, 2020, to shareholders of record as of the close of business on June 19, 2020. The indicated annual dividend rate is $0.88 per share.
CHICAGO, May 7, 2020 - Hillrom (NYSE: HRC) today announced its participation at the virtual UBS Global Healthcare Conference on May 18, 2020. Company leadership will present at 11:40 a.m. Eastern Time.